Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Case Rep Nephrol ; 2018: 1415450, 2018.
Article in English | MEDLINE | ID: mdl-29682370

ABSTRACT

Antibody-mediated rejection (ABMR) is a major cause of late renal allograft dysfunction and graft loss. Risks and benefits of treatment of late ABMR have not been evaluated in randomized clinical trials. We report on a 35-year-old patient with deterioration in renal function and progressive proteinuria 15 years after transplantation. Recurrent infections after a splenectomy following traumatic splenic rupture 3 years earlier had led to reduction of immunosuppression. Renal transplant biopsy showed glomerular double contours, 40% fibrosis/tubular atrophy, peritubular capillaritis, and positive C4d staining indicating chronic-active ABMR. ABMR treatment was initiated with steroids, plasmapheresis, and rituximab. Fourteen days later, she presented to the emergency department with fever, diarrhea, vomiting, and hypotension. Despite antibiotic treatment she deteriorated with progressive hypotension, capillary leak with pleural effusion, peripheral edema, and progressive respiratory insufficiency. She died due to septic shock five days after admission. Blood cultures showed Streptococcus pneumoniae, consistent with a diagnosis of overwhelming postsplenectomy infection syndrome, despite protective pneumococcus vaccination titers. We assume that the infection was caused by one of the strains not covered by the Pneumovax 23 vaccination. The increased immunosuppression with B cell depletion may have contributed to the overwhelming course of this infection.

2.
J Am Soc Nephrol ; 27(11): 3271-3277, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27020856

ABSTRACT

Changes in metabolite levels of the kynurenine pathway have been observed in patients with CKD, suggesting involvement of this pathway in disease pathogenesis. Our recent genetic analysis in the mouse identified the kynurenine 3-mono-oxygenase (KMO) gene (Kmo) as a candidate gene associated with albuminuria. This study investigated this association in more detail. We compared KMO abundance in the glomeruli of mice and humans under normal and diabetic conditions, observing a decrease in glomerular KMO expression with diabetes. Knockdown of kmo expression in zebrafish and genetic deletion of Kmo in mice each led to a proteinuria phenotype. We observed pronounced podocyte foot process effacement on long stretches of the filtration barrier in the zebrafish knockdown model and mild podocyte foot process effacement in the mouse model, whereas all other structures within the kidney remained unremarkable. These data establish the candidacy of KMO as a causal factor for changes in the kidney leading to proteinuria and indicate a functional role for KMO and metabolites of the tryptophan pathway in podocytes.


Subject(s)
Gene Deletion , Kynurenine 3-Monooxygenase/genetics , Proteinuria/enzymology , Proteinuria/genetics , Animals , Female , Humans , Kynurenine 3-Monooxygenase/physiology , Male , Mice , Mice, Inbred C57BL , Zebrafish
3.
Zebrafish ; 12(5): 372-6, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26125680

ABSTRACT

Analysis of genes compromising the glomerular filtration barrier in rodent models using transgenic or knockdown approaches is time- and resource-consuming and often leads to unsatisfactory results. Therefore, it would be beneficial to have a selection tool indicating that your gene of interest is in fact associated with proteinuria. Zebrafish (Danio rerio) is a rapid screening tool to study effects in glomerular filtration barrier integrity after genetic manipulation. We use either injection of high-molecular-weight dextrans or a transgenic fluorescent fish line [Tg(l-fabp:DBP:EGFP)] expressing a vitamin D-binding protein fused with eGFP for indirect detection of proteinuria. A loss of high-molecular-weight proteins from the circulation of the fish into the urine can be identified by monitoring fluorescence intensity in the zebrafish eye. Paired with an optimized analysis method, this assay provides an effective screening solution to detect filtration barrier damage with proteinuria before moving to a mammalian system.


Subject(s)
Dextrans/metabolism , Eye/metabolism , Models, Animal , Proteinuria/genetics , Zebrafish/metabolism , Animals , Animals, Genetically Modified/genetics , Animals, Genetically Modified/metabolism , Biomarkers , Green Fluorescent Proteins/metabolism , Zebrafish/genetics
4.
Nat Med ; 21(6): 601-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25962121

ABSTRACT

Dysregulation of the actin cytoskeleton in podocytes represents a common pathway in the pathogenesis of proteinuria across a spectrum of chronic kidney diseases (CKD). The GTPase dynamin has been implicated in the maintenance of cellular architecture in podocytes through its direct interaction with actin. Furthermore, the propensity of dynamin to oligomerize into higher-order structures in an actin-dependent manner and to cross-link actin microfilaments into higher-order structures has been correlated with increased actin polymerization and global organization of the actin cytoskeleton in the cell. We found that use of the small molecule Bis-T-23, which promotes actin-dependent dynamin oligomerization and thus increased actin polymerization in injured podocytes, was sufficient to improve renal health in diverse models of both transient kidney disease and CKD. In particular, administration of Bis-T-23 in these renal disease models restored the normal ultrastructure of podocyte foot processes, lowered proteinuria, lowered collagen IV deposits in the mesangial matrix, diminished mesangial matrix expansion and extended lifespan. These results further establish that alterations in the actin cytoskeleton of kidney podocytes is a common hallmark of CKD, while also underscoring the substantial regenerative potential of injured glomeruli and identifying the oligomerization cycle of dynamin as an attractive potential therapeutic target to treat CKD.


Subject(s)
Coumaric Acids/administration & dosage , Cyanoacrylates/administration & dosage , Dynamins/metabolism , Podocytes/drug effects , Proteinuria/drug therapy , Renal Insufficiency, Chronic/drug therapy , Acrylamide/administration & dosage , Actin Cytoskeleton/drug effects , Animals , Dynamins/chemistry , Dynamins/drug effects , Humans , Kidney Glomerulus/drug effects , Kidney Glomerulus/pathology , Kidney Glomerulus/ultrastructure , Mice , Models, Animal , Podocytes/pathology , Podocytes/ultrastructure , Proteinuria/metabolism , Proteinuria/pathology , Renal Insufficiency, Chronic/metabolism , Renal Insufficiency, Chronic/pathology , Zebrafish
5.
Am J Physiol Renal Physiol ; 308(12): F1444-51, 2015 Jun 15.
Article in English | MEDLINE | ID: mdl-25925250

ABSTRACT

Delayed graft function (DGF) after kidney transplantation is not uncommon, and it is associated with long-term allograft impairment. Our aim was to compare renal perfusion changes measured with noninvasive functional MRI in patients early after kidney transplantation to renal function and allograft histology in biopsy samples. Forty-six patients underwent MRI 4-11 days after transplantation. Contrast-free MRI renal perfusion images were acquired using an arterial spin labeling technique. Renal function was assessed by estimated glomerular filtration rate (eGFR), and renal biopsies were performed when indicated within 5 days of MRI. Twenty-six of 46 patients had DGF. Of these, nine patients had acute rejection (including borderline), and eight had other changes (e.g., tubular injury or glomerulosclerosis). Renal perfusion was significantly lower in the DGF group compared with the group with good allograft function (231 ± 15 vs. 331 ± 15 ml·min(-1)·100 g(-1), P < 0.001). Living donor allografts exhibited significantly higher perfusion values compared with deceased donor allografts (P < 0.001). Renal perfusion significantly correlated with eGFR (r = 0.64, P < 0.001), resistance index (r = -0.57, P < 0.001), and cold ischemia time (r = -0.48, P < 0.01). Furthermore, renal perfusion impairment early after transplantation predicted inferior renal outcome and graft loss. In conclusion, noninvasive functional MRI detects renal perfusion impairment early after kidney transplantation in patients with DGF.


Subject(s)
Delayed Graft Function/pathology , Delayed Graft Function/physiopathology , Graft Survival/physiology , Kidney Transplantation , Kidney/physiopathology , Magnetic Resonance Imaging , Adult , Aged , Female , Glomerular Filtration Rate/physiology , Graft Rejection/pathology , Humans , Kidney Transplantation/adverse effects , Kidney Transplantation/methods , Magnetic Resonance Imaging/methods , Male , Middle Aged , Perfusion/methods , Transplantation, Homologous/adverse effects , Transplantation, Homologous/methods
6.
J Am Soc Nephrol ; 25(9): 1991-2002, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24676636

ABSTRACT

FSGS is characterized by segmental scarring of the glomerulus and is a leading cause of kidney failure. Identification of genes causing FSGS has improved our understanding of disease mechanisms and points to defects in the glomerular epithelial cell, the podocyte, as a major factor in disease pathogenesis. Using a combination of genome-wide linkage studies and whole-exome sequencing in a kindred with familial FSGS, we identified a missense mutation R431C in anillin (ANLN), an F-actin binding cell cycle gene, as a cause of FSGS. We screened 250 additional families with FSGS and found another variant, G618C, that segregates with disease in a second family with FSGS. We demonstrate upregulation of anillin in podocytes in kidney biopsy specimens from individuals with FSGS and kidney samples from a murine model of HIV-1-associated nephropathy. Overexpression of R431C mutant ANLN in immortalized human podocytes results in enhanced podocyte motility. The mutant anillin displays reduced binding to the slit diaphragm-associated scaffold protein CD2AP. Knockdown of the ANLN gene in zebrafish morphants caused a loss of glomerular filtration barrier integrity, podocyte foot process effacement, and an edematous phenotype. Collectively, these findings suggest that anillin is important in maintaining the integrity of the podocyte actin cytoskeleton.


Subject(s)
Glomerulosclerosis, Focal Segmental/genetics , Microfilament Proteins/genetics , Mutation , Adaptor Proteins, Signal Transducing/metabolism , Adult , Aged , Amino Acid Sequence , Animals , Cell Movement/genetics , Conserved Sequence , Contractile Proteins/genetics , Cytoskeletal Proteins/metabolism , DNA Mutational Analysis , Disease Models, Animal , Exome , Female , Gene Knockdown Techniques , Glomerular Filtration Barrier/metabolism , Glomerulosclerosis, Focal Segmental/pathology , Humans , Male , Mice , Middle Aged , Molecular Sequence Data , Mutant Proteins/genetics , Pedigree , Podocytes/metabolism , Sequence Homology, Amino Acid , Up-Regulation , Zebrafish , Zebrafish Proteins/genetics
7.
Biomed Res Int ; 2013: 658270, 2013.
Article in English | MEDLINE | ID: mdl-24106712

ABSTRACT

Data for genes relevant to glomerular filtration barrier function or proteinuria is continually increasing in an era of microarrays, genome-wide association studies, and quantitative trait locus analysis. Researchers are limited by published literature searches to select the most relevant genes to investigate. High-throughput cell cultures and other in vitro systems ultimately need to demonstrate proof in an in vivo model. Generating mammalian models for the genes of interest is costly and time intensive, and yields only a small number of test subjects. These models also have many pitfalls such as possible embryonic mortality and failure to generate phenotypes or generate nonkidney specific phenotypes. Here we describe an in vivo zebrafish model as a simple vertebrate screening system to identify genes relevant to glomerular filtration barrier function. Using our technology, we are able to screen entirely novel genes in 4-6 weeks in hundreds of live test subjects at a fraction of the cost of a mammalian model. Our system produces consistent and reliable evidence for gene relevance in glomerular kidney disease; the results then provide merit for further analysis in mammalian models.


Subject(s)
Glomerular Filtration Barrier/pathology , Kidney Diseases/genetics , Membrane Proteins/genetics , Zebrafish/genetics , Animals , Disease Models, Animal , Glomerular Filtration Barrier/metabolism , Humans , Kidney Diseases/pathology , Morpholinos/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...